Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$851M |
| 2 |
Apple
AAPL
|
+$663M |
| 3 |
UnitedHealth
UNH
|
+$206M |
| 4 |
Cisco
CSCO
|
+$192M |
| 5 |
Johnson & Johnson
JNJ
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$559M |
| 2 |
Broadcom
AVGO
|
+$224M |
| 3 |
United Rentals
URI
|
+$189M |
| 4 |
CRH
CRH
|
+$177M |
| 5 |
Pfizer
PFE
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.61% |
| 2 | Financials | 17.11% |
| 3 | Industrials | 13.24% |
| 4 | Consumer Discretionary | 11.1% |
| 5 | Healthcare | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Ultrapar
UGP
$6.95B
| $1.49M | ﹤0.01% |
260,178
+23,612
| +10% | +$136K |
|
2852
Tandem Diabetes Care
TNDM
$1.34B
| $1.47M | ﹤0.01% |
41,536
-12,296
| -23% | -$329K |
|
2853
Arq
ARQ
$84.6M
| $1.46M | ﹤0.01% |
225,564
+37,048
| +20% | +$138K |
|
2854
Global Water Resources
GWRS
$206M
| $1.46M | ﹤0.01% |
113,727
+2,757
| +2% | +$34.5K |
|
2855
Red Violet
RDVT
$979M
| $1.46M | ﹤0.01% |
74,547
+8,067
| +12% | +$148K |
|
2856
Magyar Bancorp
MGYR
$124M
| $1.45M | ﹤0.01% |
130,065
+2,301
| +2% | +$26.2K |
|
2857
Dutch Bros
BROS
$9.03B
| $1.43M | ﹤0.01% |
43,200
+8,158
| +23% | +$241K |
|
2858
Oportun Financial
OPRT
$255M
| $1.42M | ﹤0.01% |
586,336
+13,087
| +2% | +$47.3K |
|
|
TWKS
2859
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $1.42M | ﹤0.01% |
563,126
+261,454
| +87% | +$1M |
|
2860
Nautilus Biotechnolgy
NAUT
$124M
| $1.41M | ﹤0.01% |
479,936
+78,911
| +20% | +$224K |
|
2861
KE Holdings
BEKE
$18.7B
| $1.41M | ﹤0.01% |
102,610
+11,234
| +12% | +$157K |
|
2862
Gran Tierra Energy
GTE
$265M
| $1.4M | ﹤0.01% |
196,579
+13,188
| +7% | +$73.4K |
|
2863
GSI Technology
GSIT
$215M
| $1.39M | ﹤0.01% |
407,874
-51,906
| -11% | -$150K |
|
|
CUK
2864
DELISTED
Carnival PLC
CUK
| $1.38M | ﹤0.01% |
93,782
-905
| -1% | -$13.4K |
|
2865
Quest Resource Holding
QRHC
$26.8M
| $1.38M | ﹤0.01% |
160,772
+7,063
| +5% | +$50.3K |
|
2866
Takeda Pharmaceutical
TAK
$54.6B
| $1.38M | ﹤0.01% |
99,179
+7,171
| +8% | +$104K |
|
|
PHLT
2867
DELISTED
Performant Healthcare Inc
PHLT
| $1.37M | ﹤0.01% |
465,977
+14,680
| +3% | +$42K |
|
2868
Biomea Fusion
BMEA
$84.6M
| $1.34M | ﹤0.01% |
89,865
| – | – |
|
|
INZY
2869
DELISTED
Inozyme Pharma
INZY
| $1.34M | ﹤0.01% |
174,647
+110,962
| +174% | +$609K |
|
2870
Ampco-Pittsburgh
AP
$163M
| $1.34M | ﹤0.01% |
616,363
-14,794
| -2% | -$37.2K |
|
2871
Lindblad Expeditions
LIND
$1.94B
| $1.34M | ﹤0.01% |
143,242
+96,564
| +207% | +$889K |
|
2872
Larimar Therapeutics
LRMR
$397M
| $1.33M | ﹤0.01% |
175,744
-19,444
| -10% | -$152K |
|
|
OPI
2873
DELISTED
Office Properties Income Trust
OPI
| $1.33M | ﹤0.01% |
653,015
-7,610
| -1% | -$26.1K |
|
2874
M-tron Industries
MPTI
$356M
| $1.32M | ﹤0.01% |
44,076
-5,316
| -11% | -$200K |
|
2875
MainStreet Bancshares
MNSB
$164M
| $1.32M | ﹤0.01% |
72,722
-2,923
| -4% | -$57.3K |
|
Similar funds
Dimensional Fund Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Dimensional Fund Advisors held 3,470 positions worth $369B, up 7.9% from $342B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 4.1%. Dimensional Fund Advisors opened 58 new positions and exited 83, leaving the 3,470-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2024 buy was Arcadium Lithium plc: 8,775,487 shares worth $37.8M.
- Dimensional Fund Advisors added most to NVIDIA in Q1 2024, an estimated $851M increase.
- Dimensional Fund Advisors's biggest Q1 2024 reduction was Meta Platforms (Facebook), cutting an estimated $559M.
- Dimensional Fund Advisors fully exited Textainer Group Holdings limited in Q1 2024, selling an estimated $161M.
- Dimensional Fund Advisors's ten largest holdings make up 13% of its $369B portfolio in Q1 2024.
- Dimensional Fund Advisors opened 58 new positions and closed 83 in Q1 2024.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $369B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.